EPIEN Medical, Inc. (EPMI)

EPIEN Medical was planning to go public, but the IPO was withdrawn on Mar 21, 2023.

IPO Price Range

$4.25 - $6.25

Shares Offered

4,190,476

Deal Size

$22.00M

EPIEN Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1.27	1.39	1.16
Revenue Growth (YoY)	-	19.69%	-
Cost of Revenue	-	0.34	0.33
Gross Profit	0.96	1.05	0.83
Selling, General & Admin	-	3.47	2
Research & Development	-	0.11	0.02
Operating Expenses	-	3.58	2.03
Operating Income	-2.64	-2.53	-1.2
Interest Expense / Income	1.15	0.73	0.49
Other Expense / Income	0.01	-0.12	-
Pretax Income	-3.8	-3.14	-1.69
Net Income	-3.8	-3.14	-1.69
Free Cash Flow	-2.2	-1.22	-0.59
Gross Margin	75.81%	75.41%	71.26%
Operating Margin	-207.34%	-182.31%	-103.34%
Profit Margin	-298.43%	-226.33%	-145.93%
Free Cash Flow Margin	-173.23%	-87.91%	-50.50%
EBITDA	-2.51	-2.35	-1.19
EBITDA Margin	-197.34%	-169.25%	-102.25%
Depreciation & Amortization	0.14	0.06	0.01
EBIT	-2.65	-2.41	-1.2
EBIT Margin	-208.02%	-173.58%	-103.34%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).